KN 10-K & 10-Q changes, risk factors and insider trading
Knowles Corp · NYSE · Household Audio & Video Equipment · CIK 1587523 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Implementation of our growth strategies may not be successful, which could adversely impact our results of operations.”
New heading “Issues related to the use of artificial intelligence may present business, compliance, or reputational risks.”
Removed heading “The divestiture of our Consumer MEMS Microphones ("CMM") business may have material adverse effects on our financial condition, results of operations, or cash flows.”
Removed heading “We are subject to potentially material liability for breaches of confidentiality agreements with certain of our top customers.”
Removed heading “Evolving social and environmental responsibility regulations, as well as demands from investors, customers and other stakeholders, could result in additional costs, harm to our reputation and a loss of customers.”
Largest changes
“We are subject to potentially material liability for breaches of confidentiality agreements with certain of our top customers.”see in full comparison
“Evolving social and environmental responsibility regulations, as well as demands from investors, customers and other stakeholders, could result in additional costs, harm to our reputation and a loss of customers.”see in full comparison
“Issues related to the use of artificial intelligence may present business, compliance, or reputational risks.”see in full comparison
“The divestiture of our Consumer MEMS Microphones ("CMM") business may have material adverse effects on our financial condition, results of operations, or cash flows.”see in full comparison
“Implementation of our growth strategies may not be successful, which could adversely impact our results of operations.”see in full comparison
“Recent technological advances in artificial intelligence ("AI") and machine-learning technology present new opportunities for innovation and efficiency, but also pose new risks. As the field of AI is rapidly developing, the global regulatory and legal landscape is evolving. As we introduce these technologies into our internal processes, we seek to use AI responsibly and to manage the ethical and legal issues associated with it. We may be unsuccessful in managing these issues, which could present business, compliance, or reputational risks. …”see in full comparison
Full comparison: every changed paragraph (21)
The divestiture of our Consumer MEMS Microphones ("CMM") business may have material adverse effects on our financial condition, results of operations, or cash flows.
On December 27, 2024 we consummated the sale of certain assets and liabilities of our CMM business to Syntiant Corp. While we believe the divestiture of our CMM business will place us in a better position to focus on higher value markets, we may not achieve some or all of the strategic and financial benefits that we expect to achieve, which could result in a material adverse effect to our financial condition, results of operations, or cash flows. We might experience greater dis-synergies than expected. For example, specialized suppliers may be unwilling or unable to fulfill post-divestiture reduced volumes that do not benefit from economies of scale. In addition, the impact of the divestiture on our revenue or profit might be larger than we expected. Further, we might have financial exposure in the divested business, such as through our minority equity ownership in Syntiant, our provision of financing to Syntiant, and certain financial or performance guarantees, indemnities, or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition. The separation of certain shared services following the divestiture of our CMM business will continue to require the attention of our management and place demands on other internal resources. We cannot be certain that we will be successful in managing these or any other significant risks that we encounter as a result of divesting the CMM business.
We derive a significant portion of our revenues from a limited number of OEM customers.customers and distributors. If revenues derived from these customerspartners decrease or the timing of such revenues fluctuates, our operating results could be adversely affected.
The loss of any one of our top customers or reduction in the purchases of our products by such customers or our large distribution partners would reduce our total revenues and may have a material adverse effect on our operating results, and any delay of a significant volume of purchases by any one of our top customers or distributors, even if only temporary, would reduce our revenues in the period of the delay and may have a material adverse effect on our operating results. Our MSA segment, which accounted for 45% of our consolidated revenues for fiscal 2025, relies on a limited number of customers for a significant portion of their sales. For 2025, MSA's top five customers accounted for approximately 76% of its revenues, with WS Audiology A/S accounting for approximately 24% of MSA's revenues and 11% of the consolidated Company revenues.
Our MSA segment relies on a limited number of customers for a significant portion of their sales. Our MSA segment accounted for 46% of our consolidated revenues for fiscal 2024. For 2024, MSA's top five customers accounted for approximately 81% of its revenues. For the year ended December 31, 2024, WS Audiology A/S accounted for approximately 30% of MSA's revenues and 14% of the consolidated company revenues.
The loss of any one of our top customers or a reduction in the purchases of our products by such customers would reduce our total revenues and may have a material adverse effect on our operating results, and any delay of a significant volume of purchases by any one of our top customers, even if only temporary, would reduce our revenues in the period of the delay and may have a material adverse effect on our operating results. For example, in fiscal 2022 we experienced customer purchasing adjustments due to excess inventory in the supply chain, which were partially offset by financial incentives offered to customers during the fourth quarter. Further, concentrationConcentration of market share among a few companies and the corresponding increase in purchasing power of these companies may result in lower prices for our products which, if not offset by a sufficient increase in the volume, or favorable changes in the mix, of purchases of our products, could have a material adverse effect on our revenues and margins. Further, the timing, volume, and mix of purchases by our significant customers may be impacted by the timing of such customers’ new or next generation product introductions, and the timing of such introductions may have a material adverse effect on our operating results. Accordingly, if current market and industry dynamics continue, MSA's revenues will continue to depend largely upon, and be impacted by the timing, volume, and mix of future purchases by a limited number of ourits OEM customers.
Our PD segment, which accounted for 55% of our consolidated revenues for fiscal 2025, sells through numerous distributors. However, one distributor (through whom many end customers purchase our products) represented a significant portion of PD's sales in 2025. For the year ended December 31, 2025, TTI, Inc. accounted for approximately 19% of PD's revenues and 10% of the consolidated Company revenues. No other distributor (or customer) represented more than 5% of PD's revenues for fiscal 2025. The loss of one of PD's key distributors or of a substantial number of its other distributors, or an increase in the distributors' sales of competitors' products to our customers could have a material adverse impact on our operating results. Additionally, any oversupply of inventory at our distributors, whether due to an industry or economic downturn or other causes, could result in reduced sales and cause us to carry higher levels of inventory.
Certain of our businesses rely on highly specialized suppliers or foundries for critical materials, components, or subassemblies that are used in our products. In some cases, our suppliers or foundries are our sole source of supply, such as with our ASIC and MEMS foundry partners. Additionally, some of our suppliers or foundries are a strategic supplier to one of our competitors or a customer. Should an event occur which affects the ability or willingness of a key or sole supplier or foundry to continue to deliver materials or components to us in a timely manner, we may not be able to identify or qualify an alternative supplier in a timely manner which, in any such period and future periods, could have a material adverse effect on our results of operations. Potential events or occurrences which could cause business or supply disruptions or affect the ability or willingness of a supplier or foundry to continue to supply us include changes in market strategy, the acquisition of, sale, or other change in control or ownership structure of a supplier or foundry, strategic divestiture, bankruptcy, insolvency or other financial difficulties, business disruptions (including COVID-19-related supplier plant shutdowns or slowdowns, governmental regulatory and enforcement actions,actions and work stoppages), operational issues, or capacity constraints at a supplier or foundry.
Implementation of our growth strategies may not be successful, which could adversely impact our results of operations.
Our growth strategy includes making strategic investments, including developing new products, adding new programs within our existing markets, and entering new and adjacent markets. For example, in 2025 we expanded the reach of our film capacitors into energy sectors we have not supported historically. Such strategic investments naturally entail significant risks and uncertainties, some of which are beyond our control. We may experience operational delays or encounter higher than expected production costs. In addition, some of our strategic investments depend on relationships with one or a small number of customers that are from particular industries. Any disruption in those customers' businesses, whether as a result of changes in demand for the customers' services, adverse changes in the customer's industry generally, or other challenges, could materially harm the implementation of our investment strategy with regard to a new or adjacent market or technology. We cannot, therefore, provide assurance that each of our strategic investments will be accretive or generate anticipated financial returns. If, for any of these or for unforeseen reasons, our strategic investments fail to meet our expectations or forecasts, our business and results of operations may be materially adversely affected.
If we are unsuccessful in implementing our investment and acquisition strategy, or integrating acquired companies, or managing divestitures and other significant transactions our business and financial results may be adversely effected.
We engage in strategic transactions and make strategic investments, including investments in emerging technology companies and intellectual property, which are focused on growth by positioning the Company for expansion into new markets, territories or technologies, exploiting new or growing customer or market opportunities, and developing new technologies and products. Such acquisitions and strategic investments naturally entail significant risks and uncertainties, some of which are beyond our control. To the extent we are successful in making acquisitions, such as our acquisition of Cornell Dubilier, we may not realize the expected benefits of our acquisitions or strategic transactions,acquisitions, or be able to retain those benefits even if realized. We may not, for example, be able to retain key employees, customers, or suppliers of acquired companies, derive value from acquired technology or assets, and we may experience delays in achieving cost or revenue synergies or encounter higher than expected costs in implementing them. Further, the internal control environment of an acquired entity may not be consistent with our standards or with regulatory requirements, and may require significant time and resources to align or rectify. In addition, due to our inexperience with certain adjacent or complimentary technologies and doing business in certain geographic regions that may be served by acquired businesses, we may underestimate the costs or overestimate the benefits that we expect to realize from such acquisitionsacquisitions. We have in the past, and may in the future, consider divesting certain business operations. For example, in 2024 we consummated the sale of our Consumer MEMS Microphone ("CMM") business to Syntiant Corp. Divestitures may involve a number of risks, including an impact on our revenue or investments,profit that is larger than expected. Further, we might have financial exposure in the divested business, such as through our minority equity ownership of Syntiant, our provision of financing to Syntiant, and wecertain mayfinancial notor achieveperformance them.guarantees, indemnities, or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition. We cannot, therefore, provide assurance that each of our acquisitionsacquisitions, divestitures, or strategicother investmentssignificant transactions will be accretive or generate anticipated financial returns. If, for any of these or for unforeseen reasons, our strategic acquisitions or investmentstransactions fail to meet our expectations or forecasts, our business and results of operations may be materially adversely affected.
Our products are complex and could contain defects, which could result in material costs to us. Product development in the markets we serve is becoming more focused on audio signal processing for improved audio performance and to enable intelligent and more sophisticated audio solutions. The increasing complexity of our products increases the risk that we or our customers or end users could discover latent defects or subtle faults after significant volumes of product have been shipped. This could result in material costs and other adverse consequences to us including, but not limited to: loss of customers, reduced margins, damage to our reputation, a material product recall, replacement costs for product warranty and support, payments to our customers related to recall claims as a result of various industry or business practices, a delay in recognition or loss of revenues, loss of market share or failure to achieve market acceptance, and a diversion of the attention of our engineering personnel from our product development efforts. In addition, any defects or other problems with our products could result in financial losses or other damages to our customers who could seek damages from us for their losses. A product liability or warranty claim brought against us, even if unsuccessful, would likely be time consuming and costly to defend. Due to the complex nature of our products, quality and reliability issues may be identified after significant volumes of a product have been shipped to a large customer. A warranty or product liability claim against us in excess of our available insurance coverage and established reserves, or a determination that we have liability or an obligation to cover the costs of a customer product recall, could have a material adverse effect on our business, results of operations, and financial condition.
We are subject to potentially material liability for breaches of confidentiality agreements with certain of our top customers.
We have entered into non-disclosure agreements with several of our top customers which require us not to disclose and to protect certain information regarding, among other things, aspects of those customers’ businesses plans, products, and technology. These confidentiality agreements, in some cases, impose strict liability on us in the event of any breach of these agreements by us or our employees or agents and, should such a breach occur, any resulting damage award or settlement could have a material adverse effect on our operating results and financial condition.
Global economic conditions can be uncertain and volatile. Our business and results of operations have in the past been, and may continue to be, adversely affected by changes in global economic conditions including inflation, consumer spending rates, rising interest rates, the negative impacts caused by pandemics and public health crises, such as the COVID-19 pandemic, as well as the potential impacts of geopolitical uncertainties (including the ongoing conflict between Russia and Ukraine, and China-Taiwan relations). As global economic conditions continue to be volatile or economic uncertainty remains, trends in end-user consumer spending also remain unpredictable. Many of our customers purchase our products, particularly in our MSA segment, based on end-user demand from consumers. As a result, unfavorable economic conditions may lead our customers to delay or reduce purchases of our products.
Evolving social and environmental responsibility regulations, as well as demands from investors, customers and other stakeholders, could result in additional costs, harm to our reputation and a loss of customers.
Increasing focus on environmental, social, and governance ("ESG") responsibility, as well as customer and investor demands, may make our supply chain more complex and may adversely affect our relationships with customers and investors. Some of our customers have adopted, or may adopt, procurement policies that include ESG provisions or requirements that their suppliers should comply with, or they may seek to include such provisions or requirements in their procurement terms and conditions. Also, an increasing number of investors are requiring companies to disclose corporate ESG policies, practices, and metrics. Legal and regulatory requirements, as well as investor expectations, on corporate ESG practices and disclosure, are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and manufacturing. If we are unable to comply, or are unable to cause our suppliers or contract manufacturers to comply, with such policies or provisions or meet the requirements of our customers and our investors, a customer may stop purchasing products from us or an investor may sell their shares, which could have a material adverse effect on our results of operations and our reputation. In addition, we have publicly announced certain corporate responsibility goals, which reflect our current plans and aspirations based on known conditions. Any failure to achieve such goals (or achieve the goals within the set timeframe) or the perception by stakeholders of such failure may result in reputational or financial harm.
Risks Related to Intellectual PropertyProperty, Cybersecurity, and CybersecurityTechnology
Issues related to the use of artificial intelligence may present business, compliance, or reputational risks.
Recent technological advances in artificial intelligence ("AI") and machine-learning technology present new opportunities for innovation and efficiency, but also pose new risks. As the field of AI is rapidly developing, the global regulatory and legal landscape is evolving. As we introduce these technologies into our internal processes, we seek to use AI responsibly and to manage the ethical and legal issues associated with it. We may be unsuccessful in managing these issues, which could present business, compliance, or reputational risks. In addition, our competitors may be more effective at using AI in their operations, products and services, which may put us at a competitive disadvantage.
Management's Discussion & Analysis (MD&A)
New heading “Results of Operations”
New heading “Impairment Charges”
New heading “Dividend Income”
New heading “Segment Results of Operations”
Removed heading “Results of Operations for the Year Ended December 31, 2024 compared with the Year Ended December 31, 2023”
Removed heading “Segment Results of Operations for the Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023”
Largest changes
Gross profit for the year ended December 31,see in full comparison20232025 was$203.8$256.3 million, compared with$227.0$234.8 million for the year ended December 31,2022,2024,aandecreaseincrease of$23.2$21.5 million or10.2%.9.2%. Gross profit margin (gross profit as a percentage of revenues) for the year ended December 31,20232025 was44.6%,43.2%, compared with47.4%42.4% for the year ended December 31,2022.2024. Thedecreaseincrease in gross profitwasand gross profit margin were primarily due tolowerhigher shipping volumes, company-wide product cost reductions, increased factory capacityutilization,utilization in our ceramic capacitor and RF filter businesses, a reduction of CD-related acquisition and production transfer costs, higher average pricing in PD, and lowershippingpreciousvolumes,metal costs, partially offset by unfavorable product mix,andlower-than-expectedhigheryieldsrestructuringincharges,ourpartiallyCDoffsetbusinessbyas we ramped up our specialty film productcostline,reductionslower average pricing on mature products in the MSA business, andfavorableimpairmentforeign currency exchange rate changes. The decreasecharges ingross profit margin was primarily due to lower factory capacity utilization and unfavorable product mix product, partially offset by product cost reductions and favorable foreign currency exchange rate changes.2025.
“Loss from discontinued operations for the year ended December 31, 2024 was $261.2 million, compared with earnings of $6.8 million for the year ended December 31, 2023. The decrease in earnings from discontinued operations was primarily driven by our goodwill impairment charges and unfavorable income tax changes, partially offset by the gain on sale of the CMM business and reduction in stock-based compensation expense. For additional information, refer to Note 2. Disposed and Discontinued Operations to our Consolidated Financial Statements.”see in full comparison
“(8) The non-GAAP reconciling adjustments include stock-based compensation expense, intangibles amortization expense, impairment charges, restructuring charges, production transfer costs, acquisition-related costs, and other expenses, partially offset by dividend income and a credit to transition services.”see in full comparison
The Company performed a qualitative goodwill impairmentsee in full comparisonassessmenttest foritsthethreeHPC, RFMW, and MSA reporting units and a quantitative impairment test for the CD reporting unit as of October 1,2024.2025. No goodwill impairment charges were recorded in continuing operations during the years ended December 31, 2025, 2024,2023,or2022.2023.
“Segment Results of Operations for the Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023”see in full comparison
Full comparison: every changed paragraph (111)
We are a leading manufacturer of specialty electronic components. We design parts that perform unique and critical functions for innovative technologies. Through extreme reliability, custom engineering, and scalable manufacturing, we enable businesses to succeed in the most demanding applications across medtech, defense, industrial, and industrialelectrification/energy markets. Our high performance capacitors, radio frequency ("RF") and microwave filters, advanced medtech microphones, and balanced armature speakers,speakers enable and enhance the performance of ourtechnologies customerswith productsthe power to change, improve, and save lives. Our focus on the customer, combined with unique technology, proprietary manufacturing techniques, and global operational expertise, enables us to deliver innovativecustomized solutions across multiple applications. References to "Knowles," the "Company," "we," "our," or "us" refer to Knowles Corporation and its consolidated subsidiaries, unless the context otherwise requires.
In May 2025, we held an investor day to announce the progress that we have made on our transformation into a premier industrial technology company. Our strategic plan over the last five years was deliberate and paced, starting with a significant shift in investing in research and development and capital expenditures on core technologies. This resulted in a reduction in investment in the consumer market, and an increased investment in our MSA and PD segments. We have aligned our product profile toward the medtech, defense, industrial, and electrification/energy markets, where we see favorable trends. As we focus on what we do best, designing custom engineered products and delivering them at scale for customers and markets that value our solutions, we believe that we are well-positioned for future growth.
On December 27, 2024, the Company consummated the sale and assignment of certain assets and liabilities of the Company’s Consumer MEMS Microphones (“CMM”) business to Syntiant Corp. ("Syntiant") for approximately $150.0 million in total consideration, consisting of $70.0 million cash ($58.0 million in net cash received) as adjusted for agreed deductions for indebtedness, and working capital and $80.0 million in Syntiant Series D-2 preferred stock (with a fair value of $77.2 million), par value $0.0001. The Company provided $6.4 million in financing, which was utilized to fund Syntiant's requirement to have $40.0 million of cash on its balance sheet at closing. The Company will also share in certain separation costs pursuant to a credit, which Syntiant may apply to specified separation costs post-closing. For additional information, refer to Note 2. Disposed and Discontinued Operations to our Consolidated Financial Statements under Part I, Item 1, "Financial Statements."
The CMM divestiture represents a strategic shift that will have a major effect on our operations and financial results. As a result, we have reclassified the results of operations and financial position of CMM to discontinued operations for all periods presented. Unless otherwise noted, our results of operations discussed below relate to continuing operations and will be impacted by the CMM divestiture.
This divestiture supports Knowles' continued transformation into an industrial technology company, consisting of its Precision Devices ("PD") and MedTech & Specialty Audio ("MSA") segments, primarily serving the defense, medtech, industrial, and electrification markets. We may incur some amount of dis-synergies following the sale of the CMM business due to the reduced size of our company and, as a result, we may undertake actions to help ensure that our cost structure is appropriate to support our remaining businesses.
On November 1, 2023, we acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $259.8 million, which equated to a total fair value of consideration transferred of $246.8 million. The acquired business is a manufacturer of film, electrolytic, and mica capacitors used in medtech, defense, and industrial electrification applications. The acquisition's operations are included in the PD segment. For additional information, refer to Note 3. Acquisition to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data."
At December 31, 2024,2025, we had two reporting segments: (i) PD and (ii) MSA. These segments were determined in accordance with Financial Accounting Standards Board Accounting Standards Codification 280 - Segment Reporting. We previously reflected our CMM business as a reportable segment; however, CMM's results were reclassified to discontinued operations in 2024 based on the Company's intention and eventual divestiture of this business. The results of operations and the related assets and liabilities for CMM have been classified as discontinued operations for all periods presented. The remainingThese segments are aligned around similar product applications serving our key end markets to enhance focus on end market growth strategies.
Our PD segment specializes in the custom design and delivery of high performance capacitor products and RF solutions primarily serving the defense, industrial, medtech, electrification, and industrialelectrification/energy markets. PD has sales, support, and engineering facilities in North America, Europe, and Asia,Asia as well as manufacturing facilities in North America and Asia.
Our MSA segment designs and manufactures balanced armature speakers and microphones used in hearing health and specialty audio applications that serve the hearing healthmedtech and premium audioindustrial markets. MSA has sales, support, and engineering facilities in North America, Europe, and Asia, as well as manufacturing facilities in Asia.
Revenues for the year ended December 31, 2022 were significantly impacted by lower end market demand and an inventory correction in the hearing health markets in the second half of 2022. As a result, the Company offered financial incentives to customers in the fourth quarter of 2022 for certain dual-sourced products. The additional revenues as a result of these financial incentives in the fourth quarter of 2022 were less than 2% of revenues for the year ended December 31, 2022.
In addition to the generally accepted accounting principles ("GAAP") financial measures included in this item, we have presented certain non-GAAP financial measures. We use non-GAAP measures as supplements to our GAAP results of operations in evaluating certain aspects of our business, and our executive management team and Board of Directors focus on non-GAAP items as key measures of our performance for business planning purposes. These measures assist us in comparing our performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in our opinion, do not reflect our core operating performance. We believe that our presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that we use internally for purposes of assessing our core operating performance. The Company does not consider these non-GAAP financial measures to be a substitute for the information provided by GAAP financial results. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the reconciliation included herein.
Results of Operations
Revenues
Results of Operations for the Year Ended December 31, 2024 compared with the Year Ended December 31, 2023
Revenues for the year ended December 31, 20242025 were $553.5$593.2 million, compared with $456.8$553.5 million for the year ended December 31, 2023,2024, an increase of $96.7$39.7 million or 21.2%.7.2%. PD revenues increased $78.6$28.9 million, primarilymillion due to our acquisition of the CD business, partially offset by lowerhigher demand from the medtech, defense, electrification/energy, and industrial market in our legacy PD businessmarkets, as awell resultas ofhigher continuedaverage demand weakness associated with excess customer and channel inventory.pricing. MSA revenues increased $18.1$10.8 million, primarily due to higher shipping volumes of hearingmetal healthcans productsthat drivenwe bymanufacture strongerand endsell marketto demand,Syntiant partiallyas offsetpart byof lowerour supply agreement associated with the sale of CMM, and higher shipping volumes into the specialty audio marketmarket, andpartially offset by lower average pricing on mature products. In addition, revenues in the year ended December 31, 2023 were unfavorably impacted by financial incentives offered to customers in the fourth quarter of 2022, which resulted in higher shipping volumes in the fourth quarter of 2022 and lower revenues in the first quarter of 2023.
Revenues for the year ended December 31, 2023 were $456.8 million, compared with $478.8 million for the year ended December 31, 2022, a decrease of $22.0 million or 4.6%. PD revenues decreased $21.5 million, primarily due to lower demand from the industrial, medtech, and defense markets as a result of continued demand weakness associated with excess customer and channel inventory and timing of shipments into the defense market, partially offset by our acquisition of CD. MSA revenues decreased $0.5 million primarily due to lower shipping volumes into the specialty audio market as customers reduced their inventory levels, partially offset by higher shipping volumes into the hearing health market. In addition, shipping volumes were unfavorably impacted in 2023 by financial incentives offered to customers resulting in higher shipping volumes in the fourth quarter of 2022.
Cost of goods sold ("COGS") for the year ended December 31, 20242025 was $316.8$332.5 million, compared with $251.9$316.8 million for the year ended December 31, 2023,2024, an increase of $64.9$15.7 million or 25.8%.5.0%. This increase was primarily due to ourhigher acquisitionshipping ofvolumes, CDunfavorable product mix, and lower than expected yields in our CD business as we ramped up our specialty film product line, partially offset by company-wide product cost reductions, increased factory capacity utilization in our legacyceramic PD business, partially offset by product cost reductionscapacitor and favorableRF MSAfilter productbusinesses, mix.a reduction of CD-related acquisition and production transfer costs, and lower precious metal costs.
Impairment Charges
During the year ended December 31, 2025, we recorded an impairment charge of $3.6 million to write down the carrying value of certain machinery and equipment to fair value. For additional information, refer to Note 1. Summary of Significant Accounting Policies to our Consolidated Financial Statements.
Cost of goods sold ("COGS") for the year ended December 31, 2023 was $251.9 million, compared with $251.8 million for the year ended December 31, 2022, an increase of $0.1 million. This increase was primarily due to lower factory capacity utilization and our acquisition of CD, partially offset by product cost reductions, lower shipping volumes, and favorable foreign currency exchange rate changes.
During the year ended December 31, 2025, we recorded restructuring charges of $0.8 million within Gross profit and $3.0 million within Operating expenses, primarily related to headcount reductions across the Company to rightsize operating expenses subsequent to the sale of CMM. For additional information, refer to Note 9. Restructuring and Related Activities to our Consolidated Financial Statements.
During the year ended December 31, 2023, we recorded restructuring charges of $2.5 million for severance pay and benefits related to headcount reductions within our PD segment, and $0.8 million for other costs. For additional information, refer to Note 9. Restructuring and Related Activities to our Consolidated Financial Statements.
During the year ended December 31, 2022, we recorded restructuring charges of $0.6 million for other costs within Operating expenses. For additional information, refer to Note 9. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross profit for the year ended December 31, 2024 was $234.8 million, compared with $203.8 million for the year ended December 31, 2023, an increase of $31.0 million or 15.2%. Gross profit margin (gross profit as a percentage of revenues) for the year ended December 31, 2024 was 42.4%, compared with 44.6% for the year ended December 31, 2023. The increase in gross profit was primarily due to our acquisition of CD, product cost reductions, favorable MSA product mix, and higher shipping volumes, partially offset by lower factory capacity utilization in our legacy PD business, lower average pricing on mature products in our MSA business, higher production transfer costs, and the amortization of fair value adjustments to inventory for the CD acquisition. The decrease in gross profit margin was primarily due to impacts of the acquisition of CD. Excluding the impacts of CD, gross profit margins increased primarily due to product cost reductions and favorable MSA product mix, partially offset by lower factory capacity utilization in our legacy PD business, lower average pricing on mature products in our MSA business, higher production transfer costs, and the amortization of fair value adjustments to inventory for the CD acquisition.
Non-GAAP gross profit for the year ended December 31, 2024 was $245.4 million, compared with $207.7 million for the year ended December 31, 2023, an increase of $37.7 million or 18.2%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the year ended December 31, 2024 was 44.3%, compared with 45.5% for the year ended December 31, 2023. The increase in non-GAAP gross profit was primarily due to our acquisition of CD, product cost reductions, favorable MSA product mix, and higher shipping volumes, partially offset by lower factory capacity utilization in our legacy PD business and lower average pricing on mature products in our MSA business. The decrease in non-GAAP gross profit margin was primarily due to impacts of the acquisition of CD. Excluding the impacts of CD, non-GAAP gross profit margins increased primarily due to product cost reductions and favorable MSA product mix, partially offset by lower factory capacity utilization in our legacy PD business and lower average pricing on mature products in our MSA business.
Gross profit for the year ended December 31, 20232025 was $203.8$256.3 million, compared with $227.0$234.8 million for the year ended December 31, 2022,2024, aan decreaseincrease of $23.2$21.5 million or 10.2%.9.2%. Gross profit margin (gross profit as a percentage of revenues) for the year ended December 31, 20232025 was 44.6%,43.2%, compared with 47.4%42.4% for the year ended December 31, 2022.2024. The decreaseincrease in gross profit wasand gross profit margin were primarily due to lowerhigher shipping volumes, company-wide product cost reductions, increased factory capacity utilization,utilization in our ceramic capacitor and RF filter businesses, a reduction of CD-related acquisition and production transfer costs, higher average pricing in PD, and lower shippingprecious volumes,metal costs, partially offset by unfavorable product mix, andlower-than-expected higheryields restructuringin charges,our partiallyCD offsetbusiness byas we ramped up our specialty film product costline, reductionslower average pricing on mature products in the MSA business, and favorableimpairment foreign currency exchange rate changes. The decreasecharges in gross profit margin was primarily due to lower factory capacity utilization and unfavorable product mix product, partially offset by product cost reductions and favorable foreign currency exchange rate changes.2025.
Non-GAAP gross profit for the year ended December 31, 20232025 was $207.7$263.7 million, compared with $228.1$245.4 million for the year ended December 31, 2022,2024, aan decreaseincrease of $20.4$18.3 million or 8.9%.7.5%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the year ended December 31, 20232025 was 45.5%,44.5%, compared with 47.6%44.3% for the year ended December 31, 2022.2024. The decreaseincreases in non-GAAP gross profit was primarily due to lower factory capacity utilization, lower shipping volumes, and unfavorable product mix, partially offset by product cost reductions and favorable foreign currency exchange rate changes. The decrease in non-GAAP gross profit margin waswere primarily due to lowerhigher shipping volumes, company-wide product cost reductions, increased factory capacity utilization in our ceramic capacitor and RF filter businesses, higher average pricing in PD, and lower precious metal costs, partially offset by unfavorable product mix, partiallylower-than-expected offsetyields byin our CD business as we ramped up our specialty film product cost reductionsline, and favorablelower foreignaverage currencypricing exchangeon ratemature changes.products in the MSA business.
Research and development expenses for the years ended December 31, 2024 and 2023 were $39.5 million and $32.4 million, respectively, an increase of $7.1 million or 21.9%. Research and development expenses as a percentage of revenues for the years ended December 31, 2024 and 2023 was 7.1%. The increase in expenses was primarily driven by our acquisition of the CD business, which increased expenses in our PD segment and additional development activities in our MSA segment. Expenses as a percentage of revenues remained constant.
Research and development expenses for the years ended December 31, 20232025 and 20222024 were $32.4$40.2 million and $29.3$39.5 million, respectively, an increase of $3.1$0.7 million or 10.6%.1.8%. Research and development expenses as a percentage of revenues for the years ended December 31, 20232025 and 20222024 werewas 7.1%6.8% and 6.1%, respectively.7.1%. The increase in expenses was primarily driven by additionalincreased development activities in both our MSA and PD segments as we continue to invest in our businesses.businesses Inand addition,higher ourincentive acquisition of the CD business increased expenses in our PD segment.compensation. The increasedecrease in expenses as a percentage of revenues was driven by our increased investment and lowerhigher revenues.
Selling and administrative expenses for the year ended December 31, 20242025 were $142.0$142.8 million, compared with $125.8$142.0 million for the year ended December 31, 2023,2024, an increase of $16.2$0.8 million or 12.9%.0.6%. Selling and administrative expenses as a percentage of revenues for the yearyears ended December 31, 20242025 and 20232024 were 25.7%24.1% and 27.5%,25.7%, respectively. The increase in expenses was primarily driven by ourthe acquisitionacceleration of CD,stock-based compensation expense for employees who are nearing or have reached retirement eligibility and higher incentive compensation, partially offset by lowera professionalreduction feesof andCD-related acquisition costs, the benefits of PD restructuring actionsactions, takenand inreduced theintangible prioramortization year.costs. The decrease in expenses as a percentage of revenues was driven by higher revenues, lower professional fees, and the benefits of PD restructuring actions taken in the prior year.revenues.
Selling and administrative expenses for the year ended December 31, 2023 were $125.8 million, compared with $106.3 million for the year ended December 31, 2022, an increase of $19.5 million or 18.3%. Selling and administrative expenses as a percentage of revenues for the year ended December 31, 2023 and 2022 were 27.5% and 22.2%, respectively. The increase in expenses was primarily driven by higher professional service fees and our acquisition of CD. The increase in expenses as a percentage of revenues was driven by an increase in expenses and our lower revenues.
Interest expense, net for the year ended December 31, 20242025 was $16.3$9.3 million, compared with $5.4$16.3 million for the year ended December 31, 2023,2024, ana increasedecrease of $10.9$7.0 million or 201.9%.42.9%. The increasedecrease was primarilyis due to lower imputed interest expense on our Seller Note andfrom the CD acquisition, a higherlower outstanding revolving credit facility balancebalance, asand alower resultinterest ofrates during the acquisitionyear ofended CD.December 31, 2025. For additional information on borrowings and interest expense, refer to Note 11. Borrowings to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data."
Dividend Income
Dividend income for the year ended December 31, 2025 was $6.2 million due to a non-cash dividend on the Syntiant investment in the form of additional Series D-2 shares.
Interest expense, net for the year ended December 31, 2023 was $5.4 million, compared with $3.5 million for the year ended December 31, 2022, an increase of $1.9 million or 54.3%. The increase was primarily due to imputed interest expense on our Seller Note and a higher outstanding revolving credit facility balance as a result of the acquisition of CD. For additional information on borrowings and interest expense, refer to Note 11. Borrowings to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data."
Other Expense (Income),Expense, net
Other expense for the year ended December 31, 20242025 was $0.8$3.2 million, compared with $0.7$0.8 million for the year ended December 31, 2023,2024, a change of $0.1$2.4 million. Expense in both 20242025 and 20232024 is primarily due to unfavorable foreign currency exchange rate changes.changes, partially offset by unrealized gains in our investment balances.
Other expense for the year ended December 31, 2023 was $0.7 million, compared with income of $0.4 million for the year ended December 31, 2022, a change of $1.1 million. Expense in 2023 primarily represents unfavorable foreign currency exchange rate impacts. Income in 2022 primarily represents favorable impacts from foreign currency exchange rate changes, partially offset by an adjustment to pre-spin-off pension obligations.
Provision for (Benefit from) Income Taxes and Non-GAAP Provision for Income Taxes
The effective tax rate ("ETR") for the year ended December 31, 2024 was 32.6% or a $11.3 million tax provision, compared with (75.9)% or a $28.3 million tax benefit for the year ended December 31, 2023. The change in the ETR was primarily due to the release of a portion of the valuation allowance in the U.S. and the impact of intangible property transfers recorded during 2023. The change in ETR was also impacted by the mix of earnings and losses by taxing jurisdictions.
The non-GAAP ETR for the year ended December 31, 2024 was 8.4% or a $7.7 million tax provision, compared with 22.1% or a $18.3 million tax provision for the year ended December 31, 2023. The change in the non-GAAP ETR was primarily due to increased utilization of foreign tax credits compared to the prior year. After the foreign tax credits have been fully utilized, we expect the future non-GAAP ETR to increase.
The effective tax rate ("ETR") for the year ended December 31, 20232025 was (75.9)%20.5% or a $28.3$13.1 million tax benefit,provision, compared with 24.3%32.6% or a $21.3$11.3 million tax provision for the year ended December 31, 2022.2024. The change in the ETR was primarily duerelated to the release of a portion of the valuation allowancedecrease in theU.S. Subpart F income and U.S. andGlobal theIntangible impactLow-Taxed ofIncome intangibleinclusions propertycompared transfersto in 2023.2024. The change in ETR was also impacted by the mix of earnings and losses by taxing jurisdictions.
The non-GAAP ETR for the year ended December 31, 20232025 was 22.1%11.8% or a $18.3$13.1 million tax provision, compared with 17.0%8.4% or a $20.4$7.7 million tax provision for the year ended December 31, 2022.2024. The increasechange in the non-GAAP ETR was primarily due to lowerdecreased pre-taxutilization earningsof foreign tax credits compared to the prior year. As of December 31, 2025, the foreign tax credits have been fully utilized, and we expect the lossfuture ofnon-GAAP ourETR Malaysianto tax holiday.increase.
On July 4, 2025, the One Big Beautiful Bill Act was signed into U.S. federal law. The One Big Beautiful Bill Act did not have a material impact on the Company’s fiscal 2025 financial statements and, based on our analysis, we do not anticipate a material impact on subsequent years.
Earnings from continuing operations for the year ended December 31, 20242025 was $23.4$50.9 million, compared with $65.6$23.4 million for the year ended December 31, 2023,2024, aan decreaseincrease of $42.2$27.5 million. As described above, the decreaseincrease iswas primarily due to income tax expense in 2024 compared to a benefit in 2023, higher operatinggross expenses,profit, and higherlower interest expense, and dividend income recorded in 2025, partially offset by higher grossoperating profit.expenses, other expense, and income tax expense.
Earnings from continuing operations for the year ended December 31, 2023 was $65.6 million, compared with $66.4 million for the year ended December 31, 2022, a decrease of $0.8 million or 1.2%. As described above, the decrease is primarily due to lower gross profit, higher operating expenses, increased interest expense, and unfavorable foreign currency exchange rate impacts, partially offset by a favorable change in income taxes.
Earnings before interest and income taxes from continuing operations ("EBIT") for the year ended December 31, 20242025 was $51.0$73.3 million, compared with $42.7$51.0 million for the year ended December 31, 2023,2024, an increase of $8.3$22.3 million or 19.4%.43.7%. EBIT margin (EBIT from continuing operations as a percentage of revenues) for the year ended December 31, 20242025 was 9.2%,12.4%, compared with 9.3%9.2% for the year ended December 31, 2023.2024. The increase in EBIT isand EBIT margin was primarily due to higherimproved grossoperating profitleverage from the acquisition of CD, partially offset byon higher operating expenses from the acquisition of CD. The decrease in EBIT margin is primarily due to higher operating expenses and impacts of the acquisition of CD on gross margins, partially offset byrevenues, higher gross profit.profit, and dividend income recorded in 2025.
Adjusted earnings before interest and income taxes ("Adjusted EBIT") from continuing operations for the year ended December 31, 20242025 was $107.9$120.1 million, compared with $88.2$107.9 million for the year ended December 31, 2023,2024, an increase of $19.7$12.2 million or 22.3%.11.3%. Adjusted EBIT margin (adjusted EBIT from continuing operations as a percentage of revenues) for the year ended December 31, 20242025 was 19.5%,20.2%, compared with 19.3%19.5% for the year ended December 31, 2023.2024. The increase in Adjusted EBIT is primarily due to higher non-GAAP gross profit from the acquisition of CD, partially offset by higher non-GAAP operating expenses from the acquisition of CD. The increase inand Adjusted EBIT margin was primarily due to improved operating leverage on higher revenues and higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses, and impacts of the acquisition of CD on gross margins.profit.
EBIT for the year ended December 31, 2023 was $42.7 million, compared with $91.2 million for the year ended December 31, 2022, a decrease of $48.5 million or 53.2%. EBIT margin for the year ended December 31, 2023 was 9.3%, compared with 19.0% for the year ended December 31, 2022. The change is primarily due to lower gross profit, higher operating expenses, and unfavorable foreign currency exchange rate impacts.
Adjusted EBIT from continuing operations for the year ended December 31, 2023 was $88.2 million, compared with $123.4 million for the year ended December 31, 2022, a decrease of $35.2 million or 28.5%. Adjusted EBIT margin for the year ended December 31, 2023 was 19.3%, compared with 25.8% for the year ended December 31, 2022. The decreases were primarily due to lower non-GAAP gross profit, higher non-GAAP operating expenses, and unfavorable foreign currency exchange rate impacts.
(Loss) Earnings from Discontinued Operations, net
Loss from discontinued operations for the year ended December 31, 2024 was $261.2 million, compared with earnings of $6.8 million for the year ended December 31, 2023. The decrease in earnings from discontinued operations was primarily driven by our goodwill impairment charges and unfavorable income tax changes, partially offset by the gain on sale of the CMM business and reduction in stock-based compensation expense. For additional information, refer to Note 2. Disposed and Discontinued Operations to our Consolidated Financial Statements.
EarningsLoss from discontinued operations for the year ended December 31, 20232025 was $6.8$6.7 million, compared with a loss of $496.5$261.2 million for the year ended December 31, 2022.2024. The increase in earningsLoss from discontinued operations for the year ended December 31, 2025 was primarily duedriven by adjustments to ourthe loss on sale of CMM and tax expense. Loss from discontinued operations for the year ended December 31, 2024 was primarily driven by CMM goodwill impairment charges inand 2022tax thatexpense, didpartially notoffset recurby inincome 2023from CMM operations prior to disposal and highera grossgain profit.on sale of technology. For additional information, refer to Note 2. Disposed and Discontinued Operations to our Consolidated Financial Statements.
Diluted earnings per share from continuing operations was $0.26 for the year ended December 31, 2024, compared with $0.72 for the year ended December 31, 2023, a decrease of $0.46. As described above, the decrease is primarily due to unfavorable income tax changes, higher operating expenses, and increased interest expense, partially offset by higher gross profit.
Non-GAAP diluted earnings per share for the year ended December 31, 2024 was $0.91, compared with $0.69 for the year ended December 31, 2023, an increase of $0.22. As described above, the increase was primarily due to higher non-GAAP gross profit and favorable income tax changes, partially offset by higher non-GAAP operating expenses and interest expense.
Diluted earnings per share from continuing operations was $0.72 for the years ended December 31, 2023 and 2022. As described above, the lower gross profit, higher operating expenses, increased interest expense, and unfavorable foreign currency exchange rate impacts were offset by a favorable change in income taxes.
Non-GAAP dilutedDiluted earnings per share from continuing operations was $0.58 for the year ended December 31, 2023 was $0.69,2025, compared with $1.05$0.26 for the year ended December 31, 2022,2024, aan decreaseincrease of $0.36.$0.32. As described above, the decreaseimprovement wasis primarily due to lower non-GAAPhigher gross profit, lower interest expense, dividend income recorded in 2025, and reduced share count, partially offset by higher non-GAAP operating expenses, increased interestother expense, and unfavorableincome foreigntax currency exchange rate impacts.expense.
Non-GAAP diluted earnings per share for the year ended December 31, 2025 was $1.11, compared with $0.92 for the year ended December 31, 2024, an increase of $0.19. As described above, the improvement is primarily due to higher non-GAAP gross profit, lower interest expense, and reduced share count, partially offset by higher non-GAAP income tax expense, non-GAAP operating expenses, and other expense.
(2) Production transfer costs represent duplicate costs incurred to migrate manufacturing to existing facilities.
(2) Production transfer costs represent duplicate costs incurred to consolidate or migrate manufacturing to facilities primarily within the United States. These amounts are included in the corresponding Gross profit and Earnings from continuing operations before interest and income taxes for each period presented.
What changed in the latest 10-Q
Risk Factors
There have been no material changes from the risk factors previously disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “Impairment Charges”
New heading “Earnings from Discontinued Operations, net”
New heading “Diluted Earnings per Share from Continuing Operations and Non-GAAP Diluted Earnings per Share from Continuing Operations”
New heading “Results of Operations for the Six Months Ended June 30, 2026 compared with the Six Months Ended June 30, 2025”
New heading “Cost of Goods Sold”
New heading “Impairment Charges”
New heading “Restructuring Charges”
New heading “Gross Profit and Non-GAAP Gross Profit”
New heading “Research and Development Expenses”
New heading “Selling and Administrative Expenses”
New heading “Interest Expense, net”
New heading “Other Expense, net”
New heading “Provision for Income Taxes and Non-GAAP Provision for Income Taxes”
New heading “Earnings from Continuing Operations”
New heading “Segment Results of Operations for the Six Months Ended June 30, 2026 compared with the Six Months Ended June 30, 2025”
New heading “Precision Devices”
New heading “MedTech & Specialty Audio”
Removed heading “Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes”
Removed heading “Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes”
Removed heading “Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes”
Largest changes
“Diluted Earnings per Share from Continuing Operations and Non-GAAP Diluted Earnings per Share from Continuing Operations”see in full comparison
“Segment Results of Operations for the Six Months Ended June 30, 2026 compared with the Six Months Ended June 30, 2025”see in full comparison
“Results of Operations for the Six Months Ended June 30, 2026 compared with the Six Months Ended June 30, 2025”see in full comparison
Full comparison: every changed paragraph (89)
The tariff environment remains highly dynamic. On February 20, 2026, a Supreme Court ruling invalidated certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA"). Knowles submitted refund requests and has, to date, received a portion of previously paid IEEPA tariffs. However, as a relatively small percentage of our products were subject to IEEPA tariffs, cash refunds received were not material. We will continue to monitor developments on tariff policy and evaluate any changes to the applicability of tariffs to our business as the occur.
In 2025, the United States government implemented a series of trade tariffs on goods imported into the U.S. from various other countries. On February 20, 2026, a Supreme Court ruling invalidated certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA"). Following that decision, the U.S. Court of International Trade directed Customs and Border Protection to develop a process to administer potential refunds. Knowles has historically paid IEEPA duties, and we are currently pursuing the opportunity for potential tariff refunds. However, the amount and timing of any potential recovery is uncertain. Further, following the Supreme Court's ruling invalidating IEEPA tariffs, the administration implemented a new temporary 10% global tariff under Section 122 of the Trade Act of 1974, and indicated a desire to extend tariffs under other statutes. The scope and durability of the administration's efforts to preserve a broader tariff regime remain uncertain.
Results of Operations for the Three Months Ended MarchJune 31,30, 2026 compared with the Three Months Ended MarchJune 31,30, 2025
Revenues
Revenues for the firstsecond quarter of 2026 were $153.1$166.8 million, compared with $132.2$145.9 million for the firstsecond quarter of 2025, an increase of $20.9 million or 15.8%.14.3%. Precision Devices ("PD") revenues increased $12.6$19.8 million due to higher demand in the industrial, defense,electrification, electrification,medtech, and medtechdefense markets, as well as higher average pricing. MedTech & Specialty Audio ("MSA") revenues increased $8.3$1.1 million, primarily due to higher shipping volumes into the hearing health market, partially offset by lower shipping volumes into the specialty audio market.
Cost of goods sold ("COGS") for the firstsecond quarter of 2026 was $85.9$92.1 million, compared with $78.4$81.7 million for the firstsecond quarter of 2025, an increase of $7.5$10.4 million or 9.6%.12.7%. This increase was primarily due to higher shipping volumes, higherunfavorable factoryproduct costs in our MSA business, higher costs in our CD business specialty film line as we ramp up production capacity to support our growth in the electrification market,mix, and increased production transfer costs in our ceramic capacitor business, partially offset by company-wide product cost reductions, favorable product mix in our MSA business, and increased factory capacity utilization.business.
Impairment Charges
During the second quarter of 2025, we recorded an impairment charge of $3.6 million to write down the carrying value of certain machinery and equipment to fair value. For additional information, refer to Note 1. Basis of Presentation to our Consolidated Financial Statements.
During the first quarter of 2026, we recorded restructuring charges of $0.1 million within Gross profit and $0.1 million within Operating expenses related primarily to headcount reductions within our PD segment.
During the firstsecond quarter of 2025,2026, we recorded restructuring charges of $0.5$0.1 million within Gross profit and $2.4$0.1 million within Operating expenses related primarily to headcount reductions acrosswithin our PD segment. No restructuring charges were recorded during the Companysecond to rightsize operating expenses subsequent to the salequarter of CMM.2025. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross profit for the firstsecond quarter of 2026 was $67.1$74.6 million, compared with $53.3$60.6 million for the firstsecond quarter of 2025, an increase of $13.8$14.0 million or 25.9%.23.1%. Gross profit margin (gross profit as a percentage of revenues) for the firstsecond quarter of 2026 was 43.8%,44.7%, compared with 40.3%41.5% for the firstsecond quarter of 2025. The increases in gross profit and gross profit margin were primarily due to higher shipping volumes, company-wideimpairment product cost reductions, favorable product mixcharges in our2025 MSAthat business,did not recur in 2026, pricing, and increased factory capacity utilization, partially offset by higherunfavorable factoryproduct costs in our MSA business, higher costs in our CD business specialty film line as we ramp production capacity to support our growth in the electrification market,mix and increased production transfer costs in our ceramic capacitor business.
Non-GAAP gross profit for the firstsecond quarter of 2026 was $69.7$75.7 million, compared with $55.0$64.5 million for the firstsecond quarter of 2025, an increase of $14.7$11.2 million or 26.7%.17.4%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the firstsecond quarter of 2026 was 45.5%45.4% compared with 41.6%44.2% for the firstsecond quarter of 2025. The increases in non-GAAP gross profit and non-GAAP gross profit margin were primarily due to higher shipping volumes, company-wide product cost reductions, favorable product mix in our MSA business,pricing, and increased factory capacity utilization, partially offset by higherunfavorable factoryproduct costs in our MSA business and higher costs in our CD business specialty film line as we ramp production capacity to support our growth in the electrification market.mix.
Research and development expenses for the firstsecond quarter of 2026 were $11.7$10.6 million, compared with $9.7$10.0 million for the firstsecond quarter of 2025, an increase of $2.0$0.6 million or 20.6%.6.0%. Research and development expenses as a percentage of revenues for the firstsecond quarter of 2026 and 2025 were 7.6%6.4% and 7.3%,6.9%, respectively. The increase in expenses was primarily driven by increased development activities related to new products and applications.
Selling and administrative expenses for the firstsecond quarter of 2026 were $39.4$39.2 million, compared with $37.2$35.9 million for the firstsecond quarter of 2025, an increase of $2.2$3.3 million or 5.9%.9.2%. Selling and administrative expenses as a percentage of revenues for the firstsecond quarter of 2026 and 2025 were 25.7%23.5% and 28.1%,24.6%, respectively. The increase in expenses was primarily driven by higher commissionscommissions, andan increase to our deferred compensation liability, higher incentive compensation, additional headcount within the PD segment to support future growth.growth, and annual merit increases. The decrease in expenses as a percentage of revenues was driven by higher revenues.
Interest expense for the firstsecond quarter of 2026 was $1.5$1.7 million, compared with $2.7$2.5 million for the firstsecond quarter of 2025, a decrease of $1.2$0.8 million. The decrease is primarily due to nothe absence of imputed interest expense in 2026 on our Seller Note from the CD acquisition, which was paid in full in 2025. For additional information on borrowings and interest expense, refer to Note 9. Borrowings to our Consolidated Financial Statements.
Other expense for the firstsecond quarter of 2026 was $3.4$0.4 million, compared with expense of $0.5$0.9 million for the firstsecond quarter of 2025, a change of $2.9$0.5 million. Expense in 2026 and 2025 is primarily due to unfavorable foreign currency exchange rate changes.changes, Expensepartially inoffset 2025 primarily representsby unrealized lossesgains in our investment balances.
EffectiveThe effective tax rate ("ETR") from continuing operations for the firstsecond quarter of 2026 and 2025 was (2.7)%18.6% and 150.0%,31.0%, respectively. The ETR from continuing operations for the firstsecond quarter of 2026 and 2025 includes discrete items totaling $3.8 million and $0.5$0.9 million of tax benefit,benefit and $0.1 million of tax expense, respectively. The discrete items impacting the tax benefit and provision for 2026 and 2025 are primarily attributable to stock-based compensation. Absent the discrete items, the ETR from continuing operations for the firstsecond quarter of 2026 and 2025 was 31.8%22.6% and 212.5%,30.1%, respectively. The Company accrues taxes in various countries where it generates income and applies a valuation allowance in other jurisdictions, which resulted in the benefit and provision for the firstsecond quarter of 2026 and 2025, respectively.2025. The change in the ETR from was due to the mix of earnings and losses by taxing jurisdictions and net discrete items.items, primarily stock-based compensation.
The non-GAAP ETR from continuing operations for the firstsecond quarter of 2026 and 2025 was 16.8%16.9% and 14.7%,15.9%, respectively. The non-GAAP ETR from continuing operations includes no discrete impact for the firstsecond quarter of 2026 or 2025. The change in the non-GAAP ETR was primarily due to decreased utilization of foreign tax credits and the increasemix inof incomeearnings comparedand tolosses theby priortaxing year.jurisdictions.
Earnings (Loss) from Continuing Operations
Earnings from continuing operations for the firstsecond quarter of 2026 was $11.3$18.4 million, compared with a loss of $0.4$7.8 million for the firstsecond quarter of 2025, an improvement of $11.7$10.6 million. As described above, the improvement is primarily due to higher gross profit, alower taxinterest benefit in 2026 compared to tax expense in 2025,expense, and lower interestother expense, partially offset by higher otheroperating expenseexpenses and operatinghigher expenses.income tax expense.
Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes
Earnings from continuing operations before interest and income taxes ("EBIT") for the firstsecond quarter of 2026 was $12.5$24.3 million, compared with $3.5$13.8 million for the firstsecond quarter of 2025, an increase of $9.0$10.5 million. EBIT margin (EBIT as a percentage of revenues) for the firstsecond quarter of 2026 was 8.2%,14.6%, compared with 2.6%9.5% for the firstsecond quarter of 2025. The increases in EBIT and EBIT margin were primarily due to higher gross profit, partially offset by higher other expense and operating expenses.
Adjusted earnings before interest and income taxes ("Adjusted EBIT") from continuing operations for the firstsecond quarter of 2026 was $30.1$36.1 million, compared with $21.7$27.7 million for the firstsecond quarter of 2025, an increase of $8.4 million. Adjusted EBIT margin (Adjusted EBIT from continuing operations as a percentage of revenues) for the firstsecond quarter of 2026 was 19.7%,21.6%, compared with 16.4%19.0% for the firstsecond quarter of 2025. The increases in Adjusted EBIT and Adjusted EBIT margin were primarily due to higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses and other expense.expenses.
Earnings from Discontinued Operations, net
We recorded earnings from discontinued operations of $1.0 million for the second quarter of 2026, which was driven by final adjustments to the CMM sale transaction. There was no activity for discontinued operations for the second quarter of 2025. For additional information, refer to Note 3. Discontinued Operations to our Consolidated Financial Statements.
Diluted Earnings per Share from Continuing Operations and Non-GAAP Diluted Earnings per Share from Continuing Operations
Diluted earnings per share from continuing operations was $0.21 for the second quarter of 2026, compared with $0.09 for the second quarter of 2025, an improvement of $0.12. As described above, the improvement is primarily due to higher gross profit, partially offset by higher operating expenses.
Non-GAAP diluted earnings per share from continuing operations was $0.33 for the second quarter of 2026, compared with $0.24 for the second quarter of 2025, an improvement of $0.09. As described above, the improvement is primarily due to higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses.
Results of Operations for the Six Months Ended June 30, 2026 compared with the Six Months Ended June 30, 2025
Revenues for the six months ended June 30, 2026 were $319.9 million, compared with $278.1 million for the six months ended June 30, 2025, an increase of $41.8 million or 15.0%. PD revenues increased $32.4 million due to higher demand in the industrial, electrification, defense, and medtech markets, as well as higher average pricing. MSA revenues increased $9.4 million, primarily due to higher shipping volumes into the hearing health market, partially offset by lower shipping volumes into the specialty audio market.
Cost of Goods Sold
COGS for the six months ended June 30, 2026 was $178.0 million, compared with $160.1 million for the six months ended June 30, 2025, an increase of $17.9 million or 11.2%. This increase was primarily due to higher shipping volumes and higher production transfer costs in our ceramic capacitor business, partially offset by favorable product mix in our MSA segment.
Impairment Charges
During the six months ended June 30, 2025, we recorded an impairment charge of $3.6 million to write down the carrying value of certain machinery and equipment to fair value. For additional information, refer to Note 1. Basis of Presentation to our Consolidated Financial Statements
Restructuring Charges
During the six months ended June 30, 2026, we recorded restructuring charges of $0.2 million within Gross profit and $0.2 million within Operating expenses related primarily to headcount reductions within our PD segment.
During the six months ended June 30, 2025, we recorded restructuring charges of $0.5 million within Gross profit and $2.4 million within Operating expenses related to headcount reductions across the Company to rightsize operating expenses subsequent to the sale of the CMM business. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross Profit and Non-GAAP Gross Profit
Gross profit for the six months ended June 30, 2026 was $141.7 million, compared with $113.9 million for the six months ended June 30, 2025, an increase of $27.8 million or 24.4%. Gross profit margin for the six months ended June 30, 2026 was 44.3%, compared with 41.0% for the six months ended June 30, 2025. The increases in gross profit and gross profit margin were primarily due to higher shipping volumes, impairment charges in 2025 that did not recur in 2026, increased factory capacity utilization, pricing in the PD segment, and favorable product mix in our MSA segment, partially offset by higher production transfer costs in our ceramic capacitor business.
Non-GAAP gross profit for the six months ended June 30, 2026 was $145.4 million, compared with $119.5 million for the six months ended June 30, 2025, an increase of $25.9 million or 21.7%. Non-GAAP gross profit margin for the six months ended June 30, 2026 was 45.5% compared with 43.0% for the six months ended June 30, 2025. The increases in non-GAAP gross profit and non-GAAP gross profit margin were primarily due to higher shipping volumes, increased factory capacity utilization, pricing in the PD segment, and favorable product mix in our MSA segment.
Research and Development Expenses
Research and development expenses for the six months ended June 30, 2026 were $22.3 million, compared with $19.7 million for the six months ended June 30, 2025, an increase of $2.6 million or 13.2%. Research and development expenses as a percentage of revenues for the six months ended June 30, 2026 and 2025 were 7.0% and 7.1%, respectively. The increase in expenses was primarily driven by increased development activities related to new products and applications.
Selling and Administrative Expenses
Selling and administrative expenses for the six months ended June 30, 2026 were $78.6 million, compared with $73.1 million for the six months ended June 30, 2025, an increase of $5.5 million or 7.5%. Selling and administrative expenses as a percentage of revenues for the six months ended June 30, 2026 and 2025 were 24.6% and 26.3%, respectively. The increase in expenses was primarily driven by higher commissions, additional headcount within the PD segment to support future growth, annual merit increases, higher incentive compensation, and a change in our deferred compensation liability. The decrease in expenses as a percentage of revenues was driven by higher revenues.
Interest Expense, net
Interest expense for the six months ended June 30, 2026 was $3.2 million, compared with $5.2 million for the six months ended June 30, 2025, a decrease of $2.0 million. The decrease is primarily due to the absence of imputed interest expense in 2026 on our Seller Note from the CD acquisition, which was paid in full in 2025. For additional information on borrowings and interest expense, refer to Note 9. Borrowings to our Consolidated Financial Statements.
Other Expense, net
Other expense for the six months ended June 30, 2026 was $3.8 million, compared with expense of $1.4 million for the six months ended June 30, 2025, a change of $2.4 million. Expense in 2026 and 2025 is primarily due to unfavorable foreign currency changes, partially offset by unrealized gains in our investment balances.
Provision for Income Taxes and Non-GAAP Provision for Income Taxes
The ETR from continuing operations for the six months ended June 30, 2026 and 2025 was 11.6% and 38.8%, respectively. The ETR from continuing operations for the six months ended June 30, 2026 and 2025 includes discrete items totaling $4.7 million and $0.3 million of tax benefit, respectively. The discrete items impacting the tax benefit and provision for 2026 and 2025 are primarily attributable to stock-based compensation. Absent the discrete items, the ETR from continuing operations for the six months ended June 30, 2026 and 2025 was 25.6% and 41.3%, respectively. The Company accrues taxes in various countries where it generates income and applies a valuation allowance in other jurisdictions, which resulted in the provision for the six months ended June 30, 2026 and 2025. The change in the ETR was due to the mix of earnings and losses by taxing jurisdictions and net discrete items, primarily stock-based compensation.
The non-GAAP ETR from continuing operations for the six months ended June 30, 2026 and 2025 was 16.8% and 15.4%, respectively. The non-GAAP ETR from continuing operations includes discrete items totaling $0.1 million of tax benefit and no discrete impact for the six months ended June 30, 2026 and 2025, respectively. Absent the discrete items, the non-GAAP ETR from continuing operations for six months ended June 30, 2026 and 2025 was 17.0% and 15.4%, respectively. The change in the non-GAAP ETR was primarily due to decreased utilization of foreign tax credits and the mix of earnings and losses by taxing jurisdictions.
Earnings from Continuing Operations
Earnings from continuing operations for the six months ended June 30, 2026 was $29.7 million, compared to $7.4 million for the six months ended June 30, 2025, an improvement of $22.3 million. As described above, the improvement is primarily due to higher gross profit, lower interest expense, and lower income tax expense, partially offset by higher operating expenses and higher other expense.
Earnings from continuing operations before interest and income taxes for the six months ended June 30, 2026 was $36.8 million, compared with $17.3 million for the six months ended June 30, 2025, an increase of $19.5 million. EBIT margin for the six months ended June 30, 2026 was 11.5%, compared with 6.2% for the six months ended June 30, 2025. The increases in EBIT and EBIT margin were primarily due to higher gross profit, partially offset by higher operating expenses.
Adjusted earnings before interest and income taxes from continuing operations for the six months ended June 30, 2026 was $66.2 million, compared with $49.4 million for the six months ended June 30, 2025, an increase of $16.8 million. Adjusted EBIT margin for the six months ended June 30, 2026 was 20.7%, compared with 17.8% for the six months ended June 30, 2025. The increases in Adjusted EBIT and Adjusted EBIT margin were primarily due to higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses.
We recorded a loss from discontinued operations of $0.6 million for the six months ended June 30, 2026 and a loss of $1.6 million for both the firstsix quartermonths ofended 2026June and the first quarter of30, 2025. The loss from discontinued operations for the firstsix quartermonths ofended June 30, 2026 was driven by updates to estimates regarding certain tax liabilities related to CMM's historical operations.operations, partially offset by final adjustments to the CMM sale transaction. The loss from discontinued operations for the firstsix quartermonths ofended June 30, 2025 was primarily driven by unfavorable working capital adjustments for the disposal of CMM. For additional information, refer to Note 3. Discontinued Operations to our Consolidated Financial Statements.
Diluted earnings per share from continuing operations was $0.13 for the first quarter of 2026, compared with nil for the first quarter of 2025, an improvement of $0.13. As described above, the improvement is primarily due to higher gross profit, a tax benefit in 2026 compared to tax expense in 2025, and lower interest expense, partially offset by higher other expense and operating expenses.
Non-GAAP dilutedDiluted earnings per share from continuing operations was $0.27$0.34 for the firstsix quartermonths ofended June 30, 2026, compared with $0.18$0.08 for the firstsix quartermonths ofended June 30, 2025, an improvement of $0.09.$0.26. As described above, the improvement is primarily due to higher non-GAAP gross profit and lower interest expense,profit, partially offset by higher non-GAAP operating expenses, other expense, and non-GAAP income tax expense.expenses.
Non-GAAP diluted earnings per share from continuing operations was $0.60 for the six months ended June 30, 2026, compared with $0.42 for the six months ended June 30, 2025, an improvement of $0.18. As described above, the improvement is primarily due to higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses.
(4) Other expenses include foreign currency exchange rate impacts on restructuring balances and non-recurring professional service fees related to the execution of various reorganization projects.balances. Other expenses for the firstthree quarterand ofsix months ending June 30, 2026 also includes foreign currency exchange rate adjustments related to certain balances retained subsequent to the disposal of CMM; these adjustments were not deemed material for prior2025 periods.
KN insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 9 filings (6 insiders, 11 trade dates, 432,472 shares, about $15.9M; 4 of these filings say the sales were made under a Rule 10b5-1 trading plan). Net open-market shares: -432,472 (purchases minus sales); net value about -$15.9M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Shavers Cheryl L |
Open-market sale | 6,443 | $39.27 | $253.0K |
| 2026-08-17 | Shavers Cheryl L |
Open-market sale | 175 | $39.28 | $6.9K |
| 2026-08-17 | Shavers Cheryl L |
Open-market sale |
6,443 | $39.27 | $253.0K |
| 2026-08-17 | Shavers Cheryl L |
Open-market sale |
175 | $39.28 | $6.9K |
| 2026-08-14 | Niew Jeffrey |
Open-market sale |
6,951 | $38.00 | $264.1K |
| 2026-08-13 | Niew Jeffrey |
Open-market sale |
43,049 | $38.69 | $1.7M |
| 2026-08-13 | Anderson John S. |
Open-market sale |
10,000 | $38.84 | $388.4K |
| 2026-08-12 | Niew Jeffrey |
Open-market sale |
150,000 | $39.07 | $5.9M |
| 2026-08-12 | Anderson John S. |
Open-market sale |
30,000 | $39.07 | $1.2M |
| 2026-07-27 | Cabrera Raymond D. |
Open-market sale | 6,178 | $36.28 | $224.1K |
| 2026-05-27 | Giesecke Daniel J. |
Open-market sale |
10,189 | $37.33 | $380.4K |
| 2026-05-27 | Giesecke Daniel J. |
Open-market sale |
10,012 | $37.31 | $373.5K |
| 2026-05-13 | Cabrera Raymond D. |
Option exercise | 25,210 | $16.77 | $422.8K |
| 2026-05-13 | Cabrera Raymond D. |
Shares withheld for tax | 17,599 | $36.62 | $644.5K |
| 2026-05-05 | Niew Jeffrey |
Open-market sale | 142,857 | $33.25 | $4.7M |
| 2026-05-05 | Niew Jeffrey |
Option exercise | 142,857 | $16.77 | $2.4M |
| 2026-04-30 | Bastarrica Air A. Jr. |
Open-market sale | 3,623 | $30.91 | $112.0K |
| 2026-04-29 | Bastarrica Air A. Jr. |
Open-market sale | 2,153 | $29.96 | $64.5K |
| 2026-04-28 | Li Ye Jane |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Wishart Michael S |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Shavers Cheryl L |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Crowley Daniel J |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Cardew Jason M |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Barnes Keith |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Angelini Laura |
Grant/award | 6,265 | $30.33 | $190.0K |
| 2026-04-28 | Bastarrica Air A. Jr. |
Open-market sale | 1,962 | $30.26 | $59.4K |
| 2026-04-27 | Bastarrica Air A. Jr. |
Open-market sale | 2,262 | $30.68 | $69.4K |
| 2026-02-03 | Li Ye Jane |
Gift | 7,424 | — | — |
| 2026-02-03 | Li Ye Jane |
Gift | 7,424 | — | — |
Well-known investors holding KN (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| AQR Capital Management (Cliff Asness) | 2026-06-30 | 290,443 | $12.0M | 0.0% | Reduced 2% |
| Millennium Management (Israel Englander) | 2026-06-30 | 261,661 | $10.9M | 0.01% | Added 189% |
| D. E. Shaw & Co. | 2026-06-30 | 118,907 | $4.9M | 0.0% | Added 58% |
| Point72 Asset Management (Steve Cohen) | 2026-06-30 | 133,019 | $3.4M | — | Sold out |
| Polen Capital Management | 2026-06-30 | 58,485 | $2.4M | 0.02% | New position |
| Two Sigma Investments | 2026-06-30 | 43,500 | $1.8M | 0.0% | Added 140% |
| Renaissance Technologies | 2026-06-30 | 19,700 | $817.2K | 0.0% | Reduced 73% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 17,300 | $717.6K | 0.0% | Reduced 83% |
| Gotham Asset Management (Joel Greenblatt) | 2026-06-30 | 7,703 | $319.5K | 0.0% | Reduced 46% |